{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:41:24Z","timestamp":1771519284282,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ad.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T05:22:46Z","timestamp":1627881766000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["La hidroxicloroquina como f\u00e1rmaco fundamental en dermatolog\u00eda y su papel controvertido en la COVID-19"],"prefix":"10.1016","volume":"113","author":[{"given":"D.","family":"Morgado-Carrasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ibaceta-Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Piquero-Casals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2021.07.005_bib0275","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaad.2017.01.012","article-title":"Updated recommendations on the use of hydroxychloroquine in dermatologic practice","volume":"76","author":"Fernandez","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0280","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1111\/ajd.13168","article-title":"Hydroxychloroquine in dermatology: New perspectives on an old drug","volume":"61","author":"Chew","year":"2020","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/idoj.IDOJ_280_20","article-title":"Hydroxychloroquine in dermatology and beyond: Recent update","volume":"11","author":"Sardana","year":"2020","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.ad.2021.07.005_bib0290","article-title":"To dispense or not to dispense: Lessons to be learnt from ethical challenges faced by pharmacists in the COVID-19 pandemic","author":"Cox","year":"2020","journal-title":"Dev World Bioeth."},{"key":"10.1016\/j.ad.2021.07.005_bib0295","article-title":"Competing health risks associated with the COVID-19 pandemic and response: A scoping review","author":"Baral","year":"2021","journal-title":"medRxiv."},{"key":"10.1016\/j.ad.2021.07.005_bib0300","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ad.2021.07.005_bib0305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/acr.23296","article-title":"Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients","volume":"70","author":"Mohammad","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ad.2021.07.005_bib0310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.200395","article-title":"Possible consequences of a shortage of hydroxychloroquine for patients with systemic lupus erythematosus amid the COVID-19 pandemic","volume":"47","author":"Peschken","year":"2020","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0315","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2019.07.027","article-title":"An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review","volume":"82","author":"Shipman","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.14802","article-title":"Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients","volume":"46","author":"Ototake","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0325","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamadermatol.2018.5215","article-title":"Systemic treatment for clinically amyopathic dermatomyositis at 4 tertiary care centers","volume":"155","author":"Pinard","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijwd.2017.05.001","article-title":"The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy","volume":"3","author":"Anyanwu","year":"2017","journal-title":"Int J Womens Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0335","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jid.2020.12.032","article-title":"Myeloid dendritic cells are major producers of interferon-\u03b2 in dermatomyositis and may contribute to hydroxychloroquine refractoriness","volume":"141","author":"Chen","year":"2021","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.02.034","article-title":"Adverse cutaneous reactions secondary to hydroxychloroquine in patients with dermatomyositis, lupus erythematosus, and lichen planopilaris","author":"Akabane","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0345","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jaad.2019.01.040","article-title":"Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013","volume":"80","author":"Kumar","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ad.2021.07.005_bib0355","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: Data from a French nationwide study of fifty-seven patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0360","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: A systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.07.005_bib0365","first-page":"e14903","article-title":"Successful systemic treatment outcomes of lichen planus: A single-center retrospective review","author":"Hunt","year":"2021","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.07.005_bib0370","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1111\/j.1440-0960.2010.00695.x","article-title":"Childhood actinic lichen planus: Successful treatment with antimalarials","volume":"53","author":"Ram\u00edrez","year":"2012","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0375","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1111\/ajd.12948","article-title":"Hydroxychloroquine sulphate therapy of erosive oral lichen planus","volume":"60","author":"Yeshurun","year":"2019","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0380","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0190-9622(93)70082-5","article-title":"Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial","volume":"28","author":"Eisen","year":"1993","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0385","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000439588","article-title":"Antimalarial drugs for the treatment of oral erosive lichen planus","volume":"232","author":"Rivas-Tolosa","year":"2016","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.07.005_bib0390","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19870","article-title":"The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina","author":"Vermeer","year":"2021","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0395","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12463","article-title":"The role of hydroxychloroquine in the treatment of lichen planopilaris: A retrospective case series and review","volume":"30","author":"Nic Dhonncha","year":"2017","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.07.005_bib0400","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","article-title":"Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of Lichen Planopilaris Activity Index scoring system","volume":"62","author":"Chiang","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/ijpvm.IJPVM_156_17","article-title":"Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: A randomized clinical trial","volume":"8","author":"Naeini","year":"2017","journal-title":"Int J Prev Med."},{"key":"10.1016\/j.ad.2021.07.005_bib0410","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaad.2019.03.079","article-title":"Medical therapy for frontal fibrosing alopecia: A review and clinical approach","volume":"81","author":"Ho","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0415","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1365-2133.2010.09965.x","article-title":"Frontal fibrosing alopecia: A clinical review of 36 patients","volume":"163","author":"Samrao","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0420","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2013.12.003","article-title":"Frontal fibrosing alopecia: A multicenter review of 355 patients","volume":"70","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/pde.13451","article-title":"Alopecia areata treated with hydroxychloroquine: A retrospective study of nine pediatric cases","volume":"35","author":"Yun","year":"2018","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0430","doi-asserted-by":"crossref","first-page":"220","DOI":"10.23822\/EurAnnACI.1764-1489.11","article-title":"Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study","volume":"49","author":"Boonpiyathad","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.07.005_bib0435","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2016.11.044","article-title":"Antimalarial therapy for granuloma annulare: Results of a retrospective analysis","volume":"76","author":"Grewal","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0440","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000086452","article-title":"Treatment of generalized granuloma annulare with hydroxychloroquine","volume":"211","author":"Cannistraci","year":"2005","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.07.005_bib0445","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archderm.144.1.118","article-title":"Successful treatment of necrobiosis lipoidica with antimalarial agents","volume":"144","author":"Durupt","year":"2008","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0450","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-4632.2010.04149.x","article-title":"Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine","volume":"49","author":"Kavala","year":"2010","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0455","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0460","first-page":"351","article-title":"Micropapular cutaneous sarcoidosis: Case series successfully managed with hydroxychloroquine sulfate","volume":"81","author":"Modi","year":"2008","journal-title":"Cutis."},{"key":"10.1016\/j.ad.2021.07.005_bib0465","first-page":"312","article-title":"Ulcerative sarcoidosis: A prototypical presentation and review","volume":"100","author":"Powell","year":"2017","journal-title":"Cutis."},{"key":"10.1016\/j.ad.2021.07.005_bib0470","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0475","first-page":"286","article-title":"A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients","volume":"1","author":"Marchesi","year":"1984","journal-title":"Photodermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0480","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0378-6323.38401","article-title":"Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: A randomized, double-blind, multicentric study","volume":"74","author":"Pareek","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.ad.2021.07.005_bib0485","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2133.1987.tb05852.x","article-title":"Hydroxychloroquine in polymorphic light eruption: A controlled trial with drug and visual sensitivity monitoring","volume":"116","author":"Murphy","year":"1987","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0490","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0190-9622(08)81962-7","article-title":"Antimalarials for children","volume":"30","author":"Maga\u00f1a-Garc\u00eda","year":"1994","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0495","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2020.05.050","article-title":"Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: A multicenter, randomized, double-blind, double-dummy, pilot study","volume":"84","author":"Wang","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0500","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2133.1996.tb07635.x","article-title":"Hydroxychloroquine and chronic erythema nodosum","volume":"134","author":"Jarrett","year":"1996","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.07.005_bib0505","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ad.2020.09.004","article-title":"Familiar dermatologic drugs as therapies for COVID-19","volume":"112","author":"Ortega-Pe\u00f1a","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2021.07.005_bib0510","doi-asserted-by":"crossref","first-page":"e13829","DOI":"10.1111\/dth.13829","article-title":"Treatment of COVID 19-repurposing drugs commonly used in dermatology","volume":"33","author":"Stojkovic-Filipovic","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.07.005_bib0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2021.03.002","article-title":"The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 \u2014 a systematic review and meta-analysis","author":"Choudhuri","year":"2021","journal-title":"Indian J Med Microbiol."},{"key":"10.1016\/j.ad.2021.07.005_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/annrheumdis-2020-218164","article-title":"Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: Experience of the Systemic Lupus International Collaborating Clinics","volume":"80","author":"Mendel","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2021.07.005_bib0525","doi-asserted-by":"crossref","first-page":"e13524","DOI":"10.1111\/dth.13524","article-title":"The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic","volume":"33","author":"Shah","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.07.005_bib0530","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4269\/ajtmh.20-0290","article-title":"Chloroquine and hydroxychloroquine for the prevention or treatment of novel coronavirus disease (COVID-19) in Africa: Caution for inappropriate off-label use in healthcare settings","volume":"102","author":"Abena","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.ad.2021.07.005_bib0535","first-page":"CD013587","article-title":"Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ad.2021.07.005_bib0540","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa2021801","article-title":"A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19","volume":"384","author":"Mitj\u00e0","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021002970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021002970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:53:36Z","timestamp":1748019216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731021002970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0001731021002970"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2021.07.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La hidroxicloroquina como f\u00e1rmaco fundamental en dermatolog\u00eda y su papel controvertido en la COVID-19","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}